dulaglutide vs semaglutide vs tirzepatide Comparative safety and side effects of and tirzepatide: Implications for clinical decision-making in obesity management A trial emulation in Nature

Pain 13 , 807811 (2009)

Published in JAMA Network Open in 2024, the research dives into whether bariatric surgery or GLP-1 receptor agonist drugs offer a better shot at extending life for those battling both conditions

In SURMOUNT-2, participants taking Zepbound 15 mg achieved weight reductions of 16%, losing an average of 34 pounds

This chart, and this blog, are for informational purposes only, and not intended to substitute or replace medical advice

(2014) reported that ovarian cancer patients receiving IV Vitamin C alongside chemotherapy experienced fewer side effects and delayed disease progression by nearly 9 months compared to chemotherapy alone

If you have a personal or family history of medullary thyroid cancer, MEN 2, or pancreatitis, raise it with your provider before starting either drug